A case of vasospastic angina showing resolution of coronary vasospasm in acetylcholine provocation test corresponding to regression of coronary atherosclerosis

International Journal of Cardiology

Volumn 125, Issue 1, 2008, Pages

  Tani, Shigemasa ^a,b   Watanabe, Ikuyoshi ^a,b   Anazawa, Takeo ^a,b   Kawamata, Hirofumi ^a,b   Tachibana, Eizo ^a,b   Fuji, Takeshi ^a,b   Matsumoto, Michiaki ^a,b   Onikura, Motoyuki ^a,b   Sato, Yuichi ^a,b   Nagao, Ken ^b   Kanmatsuse, Katsuo ^a,b   Kushiro, Toshio ^a,b   Hirayama, Atsushi ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Benidipine; Coronary vasospasm; Intravascular ultrasound; Statin

Indexed keywords

ACETYLCHOLINE; BENIDIPINE; PRAVASTATIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY SPASM; DRUG EFFECT; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; REMISSION; TREATMENT OUTCOME;

ACETYLCHOLINE; ANGINA PECTORIS; ANGINA PECTORIS, VARIANT; ANTICHOLESTEREMIC AGENTS; CHOLINERGIC AGENTS; CORONARY ARTERY DISEASE; CORONARY VASOSPASM; DIHYDROPYRIDINES; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PRAVASTATIN; VASODILATOR AGENTS;

EID: 39749177071     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.218     Document Type: Article

References (6)

1. Koyama J., Yamagishi M., Tamai J., Kawano S., Daikoku S., and Miyatake T. Comparison of vessel wall morphologic appearance at sites of focal and diffuse coronary vasospasm by intravascular ultrasound. Am Heart J 130 (1995) 440-445
2. Motoyama T., Kawano H., Kugiyama K., et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 32 (1998) 1672-1679
3. Morita H., Saito Y., Ohashi N., et al. Fluvastatin ameliorates the hyperhomocysteinemia-induced endothelial dysfunction: the antioxidative properties of fluvastatin. Circ J 69 (2005) 475-480
4. Ito A., Fukumoto Y., and Shimokawa H. Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers. J Cardiovasc Pharmacol 44 (2004) 480-485
5. Tani S., Watanabe I., Anazawa T., et al. Surugadai atherosclerosis regression investigators. Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound. Am J Cardiol 96 (2005) 1089-1094
6. Holvoet P., Vanhaecke J., Janssens S., Van de Werf F., and Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98 (1998) 1487-1494